Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations
CAMBRIDGE, Mass. and SUZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the appointment of Angela (Hui) Yan as President of China and Asia Development and Operations. In this role, Ms. Yan will lead Kira's China division, overseeing clinical development execution and strategy as well as operational excellence for China and Asia. "We are excited to welcome a leader of Angela's caliber to oversee our China and Asia business,...
Source: singaporestar.com